IMPLICATIONS OF THE REVISED SURVEILLANCE DEFINITION - AIDS AMONG NEW-YORK-CITY DRUG-USERS

被引:11
作者
JARLAIS, DCD
WENSTON, J
FRIEDMAN, SR
SOTHERAN, JL
MASLANSKY, R
MARMOR, M
YANCOVITZ, S
BEATRICE, S
机构
[1] NATL DEV & RES INST INC, NEW YORK, NY 10013 USA
[2] BELLEVUE HOSP CTR, CTR ADDICT TREATMENT, NEW YORK, NY 10016 USA
[3] NYU, NEW YORK, NY 10003 USA
[4] NEW YORK CITY DEPT HLTH, NEW YORK, NY 10013 USA
关键词
D O I
10.2105/AJPH.82.11.1531
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
The centers for Disease Control (CDC) has proposed revising the AIDS surveillance definition to include any HIV-seropositive person with a CD4 cell count of less than 200 cells per microliter. Based on a study of persons receiving treatment for HIV infection, this new definition would lead to an estimated 50% increase in the number of persons recognized as living with AIDS. Among 440 HIV-seropositive research subjects recruited from drug treatment programs and through street out-reach in New York City, 59 met this definition, yet only 25% of those had been reported to the New York City AIDS registry. The new definition, if combined with HIV and T-cell testing at drug treatment and street outreach programs, could thus yield very large increases in the number of injecting drug users meeting the new surveillance definition of AIDS.
引用
收藏
页码:1531 / 1533
页数:3
相关论文
共 12 条
[1]  
BROWN LS, 1989, 5TH INT C AIDS
[2]   HIV-1 INFECTION AMONG INTRAVENOUS DRUG-USERS IN MANHATTAN, NEW-YORK-CITY, FROM 1977 THROUGH 1987 [J].
DESJARLAIS, DC ;
FRIEDMAN, SR ;
NOVICK, DM ;
SOTHERAN, JL ;
THOMAS, P ;
YANCOVITZ, SR ;
MILDVAN, D ;
WEBER, J ;
KREEK, MJ ;
MASLANSKY, R ;
BARTELME, S ;
SPIRA, T ;
MARMOR, M .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1989, 261 (07) :1008-1012
[3]   SPECTRUM OF DISEASE IN PERSONS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION IN THE UNITED-STATES [J].
FARIZO, KM ;
BUEHLER, JW ;
CHAMBERLAND, ME ;
WHYTE, BM ;
FROELICHER, ES ;
HOPKINS, SG ;
REED, CM ;
MOKOTOFF, ED ;
COHN, DL ;
TROXLER, S ;
PHELPS, AF ;
BERKELMAN, RL .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1992, 267 (13) :1798-1805
[4]  
JARLAIS DCD, 1987, AIDS, V1, P105
[5]   CHANGES IN LYMPHOCYTE-T SUBSETS IN INTRAVENOUS-DRUG-USERS WITH HIV-1 INFECTION [J].
MARGOLICK, JB ;
MUNOZ, A ;
VLAHOV, D ;
SOLOMON, L ;
ASTEMBORSKI, J ;
COHN, S ;
NELSON, KE .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1992, 267 (12) :1631-1636
[6]  
MINKOFF HL, 1991, JAMA-J AM MED ASSOC, V266, P2253
[7]  
*NY CIT DEP HLTH, 1991, AIDS SURV UPD 3RD QU
[8]   INCREASED RISK OF BACTERIAL PNEUMONIA IN HIV-INFECTED INTRAVENOUS DRUG-USERS WITHOUT AIDS [J].
SELWYN, PA ;
FEINGOLD, AR ;
HARTEL, D ;
SCHOENBAUM, EE ;
ALDERMAN, MH ;
KLEIN, RS ;
FRIEDLAND, GH .
AIDS, 1988, 2 (04) :267-272
[9]   A LARGER SPECTRUM OF SEVERE HIV-1-RELATED DISEASE IN INTRAVENOUS DRUG-USERS IN NEW-YORK-CITY [J].
STONEBURNER, RL ;
JARLAIS, DCD ;
BENEZRA, D ;
GORELKIN, L ;
SOTHERAN, JL ;
FRIEDMAN, SR ;
SCHULTZ, S ;
MARMOR, M ;
MILDVAN, D ;
MASLANSKY, R .
SCIENCE, 1988, 242 (4880) :916-919
[10]   HIGH-RISK OF HUMAN PAPILLOMAVIRUS INFECTION AND CERVICAL SQUAMOUS INTRAEPITHELIAL LESIONS AMONG WOMEN WITH SYMPTOMATIC HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION [J].
VERMUND, SH ;
KELLEY, KF ;
KLEIN, RS ;
FEINGOLD, AR ;
SCHREIBER, K ;
MUNK, G ;
BURK, RD .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1991, 165 (02) :392-400